NCT04464239View on ClinicalTrials.gov

A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

January 21, 2021

Study Completion Date

January 21, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

TS-142

TS-142 tablets

DRUG

TS-142 Placebo

TS-142 matching placebo tablets

Trial Locations (1)

78744

PPD Phase I unit, Austin

All Listed Sponsors
lead

Taisho Pharmaceutical R&D Inc.

INDUSTRY

NCT04464239 - A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants | Biotech Hunter | Biotech Hunter